Compare Dr. Reddy's Laboratories Ltd Common Stock (RDY) vs Shell PLC (SHEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dr. Reddy's Laboratories Ltd Common Stock vs Shell PLC — how do they compare? Dr. Reddy's Laboratories Ltd Common Stock trades at $13 (market cap $10.61B), while Shell PLC trades at $104.1 (market cap $294.95B). The key difference: Shell PLC is far larger — about 27.8× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Shell PLC pays the higher dividend (3.02%). Which is the better fit depends on your goals — on Pluang, investors hold Dr. Reddy's Laboratories Ltd Common Stock for 0 Days and Shell PLC for 91 Days on average.
| RDY | SHEL | |
|---|---|---|
Market Cap | $10.61B | $294.95B |
Volume | 3,738,869 | 6,021,309 |
Sector | Health | Energy |
52-Week High | $15.38 | $103.58 |
52-Week Low | $11.38 | $70.31 |
Typical Hold Time | 0 Days | 91 Days |
Enterprise Value | $10.51B | $336.65B |
Dividend Yield | 0.65% | 3.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Shell (SHEL) trades at $102.99, up 1.38% with a bullish technical signal from moving averages. The stock shows strong fundamentals with an 11.46 P/E ratio and 14.35% ROE, though revenue has declined from $381.3B in 2022 to $266.9B in 2025. Recent Q2 2026 earnings beat expectations at $3.52 EPS versus $3.23, and the company is expanding LNG capacity with the Phase 2 Canada project.
Outlook remains positive with 61.5% analyst buy ratings and a $103.24 consensus target, but risks include volatile oil prices and execution challenges in new projects. The current price near 52-week highs suggests limited short-term upside without new catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Dr. Reddy's Laboratories Ltd Common Stock
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →About Shell PLC
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Read more on SHEL →
